FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Istodax Indication Withdrawn After Confirmatory Trial

Bristol Myers Squibb decides to withdraw a 2011 indication granted to subsidiary Celgene under accelerated approval for Istodax (romidepsin), a histon...

Human Drugs

Multiple Violations at Farmakeio Outsourcing

FDA warns Farmakeio Outsourcing about violations at its Texas drug facility.

Human Drugs

FDA Accepts Tecentriq sBLA for Priority Review

FDA accepts a Genentech sBLA for a new indication for Tecentriq and grants it priority review.

Medical Devices

Philips Respironics Recalls V60 Ventilators

Philips Respironics recalls its V60 and V60 Plus ventilators that provide High Flow Therapy, due to a risk to the patients if the system pressure reac...

Federal Register

Info Collection on Device Recall Authority

Federal Register notice: FDA sends to OMB an information collection extension entitled Medical Device Recall Authority--21 CFR Part 810.

Federal Register

Comments Extended on Drug Security Guide

Federal Register notice: FDA extends the comment period for a 6/4 notice about a draft guidance entitled Enhanced Drug Distribution Security at the Pa...

Human Drugs

CGMP Issues at Syntec Pharma

FDA warns Syntec Pharma about CGMP deviations in its production of active pharmaceutical ingredients.

Medical Devices

Abbott Imaging Software Platform Cleared

FDA clears an Abbott 510(k) for its latest optical coherence tomography (OCT) imaging platform powered by the companys new Ultreon Software.

Human Drugs

Clinical Hold Lifted on Novartis Gene Therapy

FDA lifts a partial clinical hold against a Novartis investigational gene therapy OAV-101 intrathecal clinical trial for spinal muscular atrophy.

FDA General

Senate Subcommittee Gives FDA $200 Million Budget Boost

A Senate appropriations subcommittee votes to advance FDAs fiscal year 2022 budget with a $200 million (6%) spending boost.